A GLP-1 Deep Dive
US$ 28.14
dual gip and glp-1 receptor agonist Frontiers Potential Use of GLP-1 and
Description
Diabetes 67, 17101719 (2018)
Despite the possibility of adverse events, GLP-1 RAs continue to represent a crucial therapeutic modality for metabolic disturbances
The following counseling tips can help dietitians, and all clinicians, improve short- and long-term use of these weight management medications
Notably, the oral version is only approved for diabetes, not weight loss, and may cause more gastrointestinal side effects
This guide will help
DAD has served in an advisory role for Structure Therapeutics and Eli Lilly
